GUIDELINES RAPID REVIEW I / EXAMEN RAPIDE DES LIGNES DIRECTRICES I

Sunday, October 29, 2023

09:45 – 10:45 EST

Location: Palais, 518ABC

Target Audience: All cardiovascular (clinical and research) health professionals , Trainee (clinical)

Chair(s)

Jonathan Howlett

Dr
Cumming School of Medicine, University of Calgary
University of Calgary

Presenter(s)

Christopher Fordyce, MD (he/him/his)

Associate Professor
University of British Columbia
Division of Cardiology, University of British Columbia
Peter Guerra, MD, CM, FCCS

Chief of Medicine
CHRS
Institut de Cardiologie de Montréal
Christine Pacheco, MD, MSc, FRCPC

Cardiologist
Hôpital Pierre-Boucher, Centre Hospitalier de l'Université de Montréal (CHUM)
Université de Montréal

Planning Committee Member(s)

Ross Davies

Cardiologist
University of Ottawa Heart Institute
University of Ottawa

Disclosure(s):

Jonathan Howlett: AstraZeneca: Consultant/Advisory Board (Terminated, May 30, 2023), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, May 30, 2023), Speaker/Honoraria (Terminated, May 30, 2023); Bayer: Consultant/Advisory Board (Terminated, May 31, 2022), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, May 31, 2022); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Merck: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, September 26, 2021); Novartis: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Servier: Consultant/Advisory Board (Terminated, October 30, 2022), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 30, 2022), Speaker/Honoraria (Terminated, October 30, 2022)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

list the top key messages and recommendations from the latest Guidelines and CPUs;
apply Guideline recommendations and CPU guidance in practice, individualizing for unique patient needs; and
understand changes and updates in CCS’s Guidelines portfolio.

CCS Guidelines and Clinical Practice Updates - Top Notes You Need